What is the impact of a novel MED12 variant on syndromic conotruncal heart defects? Analysis of case report on two male sibs by Silvia Amodeo, Giuseppe Vitrano, Melania Guardino, Giuseppe Paci, Fulvio Corselli, Vincenzo Antona, Giuseppe Barrano, Monia Magliozzi, Antonio Novelli, Renato Venezia, Giovanni Corsello
CASE REPORT Open Access
What is the impact of a novel MED12
variant on syndromic conotruncal heart
defects? Analysis of case report on two
male sibs
Silvia Amodeo1, Giuseppe Vitrano1, Melania Guardino2*, Giuseppe Paci1, Fulvio Corselli1, Vincenzo Antona2,
Giuseppe Barrano3, Monia Magliozzi4, Antonio Novelli4, Renato Venezia1 and Giovanni Corsello2
Abstract
Background: Syndromic congenital heart disease accounts for 30% of cases and can be determined by genetic,
environmental or multifactorial causes. In many cases the etiology remains uncertain. Many known genes are
responsible for specific morphopathogenetic mechanisms during the development of the heart whose alteration
can determine specific phenotypes of cardiac malformations.
Case presentation: We report on two cases of association of conotruncal heart defect with facial dysmorphisms in
sibs. In both cases the malformations’ identification occurred by ultrasound in the prenatal period. It was followed
by prenatal invasive diagnosis. The genetic analysis revealed no rearrangements in Array-CGH test, while gene panel
sequencing identified a new hemizygous variant of uncertain significance (c.887G > A; p.Arg296Gln) in the MED12
gene, located on the X chromosome and inherited from the healthy mother.
Conclusion: No other reports about the involvement of MED12 gene in syndromic conotruncal heart defects are
actually available from the literature and the international genomic databases. This novel variant is a likely
pathogenic variant of uncertain significance and it could broaden the spectrum of genes involved in the
development of congenital heart diseases and the phenotypic range of MED12-related disorders.
Keywords: Congenital heart diseases, Conotruncal heart defects, Facial dysmorphisms, MED12, Echocardiography,
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Background
Conotruncal heart defects (CTDs), account for approxi-
mately 30% of congenital heart disease (CHDs). They are
characterized by anomalies of the cardiac outflow tract or of
the great arteries [1]. These include common arterial trunk
(CAT) and aorto-pulmonary window (APW), as well as
double outlet right ventricle (DORV), tetralogy of Fallot
(TOF) with or without pulmonary atresia (PA), transposition
of the great arteries (TGA), interrupted aortic arch (IAA).
CAT is characterized by a single great artery arising
from the ventricles, giving origin to aorta, coronary ar-
teries and pulmonary arteries, and by a ventricular septal
defect (VSD) [2]. According to the Collett and Edwards’
Classification [3], CAT is distinguished in: type I when a
single pulmonary trunk arises from the truncus arterio-
sus, type II when two pulmonary branches arise sepa-
rated but close from the posterior wall of the truncus
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arteriosus, type III when two pulmonary branches arise
separated from lateral walls of the truncus arteriosus.
Type IV now is defined pulmonary atresia with ventricu-
lar septal defect (PAVSD).
Aorto-pulmonary window (APW) is a communication
between the ascending aorta and the pulmonary artery
in the presence of separate semilunar valves [4]. It was
classified by Richardson into three types [5]: in type I
the defect between the aorta and the main pulmonary
artery is immediately above the sinuses of Valsalva, in
type II the defect is located more distally between the as-
cending aorta and the origin of the right pulmonary ar-
tery and in type III there is anomalous origin of the
right pulmonary artery from the ascending aorta.
Both CAT and APW are determined by the failure of
septation of the physiologic arterial common trunk into
aorta and pulmonary artery trunk during development
of the ventricular outlets and proximal arterial segment
of the heart tube.
We report on a novel variant in the MED12 gene, de-
tected by Next Generation Sequencing (NGS), associated
with recurrent conotruncal heart defects, CAT and




A couple, 33 year-old woman and 34 years-old man, re-
ferred to Prenatal Diagnostic Unit of Policlinico Univer-
sitario Paolo Giaccone for a routine mid-trimester
ultrasound scan of their first pregnancy. Conception was
spontaneous, there was no consanguinity and the couple
was in excellent health without any medical history.
They had decided to not perform the first trimester
screening for fetal aneuploidy.
The mid-trimester ultrasound scan, performed at 20.1
weeks of gestation, showed a male fetus with normal
four-chamber view but abnormal outflow tract views: a
single great artery equal overrode a ventricular septal de-
fect (VSD) (Fig. 1a). The main pulmonary trunk and
subsequent bifurcation arose from the single great artery
immediately distal to the truncal valve. Color Doppler
confirmed the blood flow through the VSD, the overrid-
ing artery, the origin of the pulmonary artery and its bi-
furcation. This finding suggested a diagnosis of truncus
arteriosus type I with VSD according to the Collett and
Edwards’ Classification [3]. Ultrasound research of asso-
ciated extra-cardiac abnormalities has highlighted micro-
retrognathia and nuchal edema (Fig. 1b and c).
CAT is often associated with extra-cardiac anomalies
in the context of specific syndromes, the most common
is 22q11 microdeletion [2], so, following genetic counsel-
ing, amniocentesis for karyotype and Array-CGH (array
comparative genomic hybridization) was performed. The
Array-CGH was performed with CytoSure ISCA v2 Ar-
rays 8x60k. Both the standard karyotype and the CGH-
arrays were negative (arr (1–22) × 2,(XY)× 1).
The couple opted for the voluntary termination of the
pregnancy and, on the advice of geneticists, requested to
store fetal DNA.
Case 2
One year later, the same couple referred again to our
Prenatal Diagnostic Unit for the second pregnancy at
Fig. 1 Case 1 mid-trimester ultrasound scan. a single great artery that equal overrode a ventricular septal defect; b microretrognathia; c
nuchal edema
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12.5 weeks of gestation for first trimester combined
screening for fetal aneuploidy. Free β-hCG and PAPP-A
were 1.397 MoM and 1.55 MoM. Nuchal translucency
was 1.4 mm, nasal bone present, FHR 159 bpm, ductus
venosus PI 1.15 and tricuspid regurgitation and microre-
trognathia were detected (Fig. 2a). Ultrasound showed
no other fetal anomalies evaluable at the first trimester.
Patient-specific risks for trisomy 21, 18, 13, computed
based on the FMF algorithm, were 1/350, 1/1862 and <
1/20.000 respectively. Considering the tricuspid regurgi-
tation and microretrognathia and the history of fetal
malformation in the previous pregnancy, following gen-
etic counseling, the couple declined villocentesis via
karyotype and microarray analysis. Therefore, early fetal
echocardiography was performed at 18 weeks: three ves-
sels and trachea view showed a communication between
aorta and pulmonary artery immediately above the si-
nuses of Valsalva, so an aorto-pulmonary window type I
according to Richardson’s Classification [5] (Fig. 2b) and
thymic hypoplasia. A detailed ultrasound to assess fetal
anatomy confirmed the microretrognathia in male fetus.
Therefore, following genetic counseling, the couple ac-
cepted amniocentesis for karyotype and Array-CGH.
The Array-CGH was performed with SurePrint G3 Hu-
man CGH Microarray 8x60k. Again, both the standard
karyotype and the Array-CGH were negative (arr (1–22)
× 2,(XY)× 1) and the couple decided to the voluntary ter-
mination of the pregnancy and to store fetal DNA.
The autopsy of aborted fetuses confirmed in both male
sibs the conotruncal heart defects, truncus arteriosus in
the first fetus and aorto-pulmonary window in the sec-
ond, the same facial dysmorphisms (microretrognathia,
small mouth, low-set ears) and sandal gap (Fig. 3).
Considering the recurrence of the association of cono-
truncal hearts disease and facial anomalies in both sibs,
obtained informed consent for genetic testing, molecular
genetic study was performed on genomic fetal DNA ex-
tracted from amniotic fluid through Next Generation Se-
quencing (NGS), evaluating cardiopathy-associated
genes (Table 1). We used targeted resequencing with a
uniquely customized design SeqCap EZ Custom Enrich-
ment Kit (Roche Life Science) on Illumina sequencing
platform (NextSeq550, San Diego, CA). We used the
BaseSpace pipeline (Illumina, https://basespace.illumina.
com/) and the VariantStudio software (Illumina, http://
variantstudio.software.illumina.com/) for the variant call-
ing and annotating variants, respectively. Sequencing
data were aligned to the hg19 human reference genome.
We analyzed the variants in silico by using Scale-
Invariant Feature Transform (SIFT), Polymorphism Phe-
notyping v2 (PolyPhen-2) for the prediction of deleteri-
ous non-synonymous SNVs for human diseases. The
analysis revealed the hemizygous variant, NM_005120.2:
c.887G > A (p.Arg296Gln) in MED12 gene located on
the X chromosome. Sanger sequencing following a
standard protocol (BigDye Terminator v3.1 Cycle Se-
quencing Kit, Applied Biosystems by Life Technologies)
confirmed the variant and we tested it for familial segre-
gation using the maternal DNA and the fetal DNA from
the first pregnancy showing the heterozygous and hemi-
zygous state respectively. This finding may explain the
fetal phenotype and X-linked trasmission. The whole ex-
ome sequencing (WES) was not performed in relation to
the diagnostic relevance of the genetic results.
Discussion and conclusions
The prenatal finding of recurrent CTDs, truncus arterio-
sus and aorto-pulmonary window respectively, associ-
ated with facial dysmorphisms in an Italian family gave
us the suspicious of a syndromic CHDs¸ inducing the
search for a possible genetic cause.
Fig. 2 Case 2 ultrasound finding. a first-trimester ultrasound scan shows microretrognathia; b three vessels and trachea view shows the
communication between aorta and pulmonary artery (aorto-pulmonary window)
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Congenital heart defects (CHDs) are structural defects
due to abnormal cardiac development in embryos. Ap-
proximately 70% of CHDs present as an isolated malfor-
mation (non-syndromic CHD), while 30% are syndromic
because in association with other extra-cardiac anomal-
ies [6]. Causes of CHDs are genetic in 8%, environmental
in 2% and multifactorial or not determined in about 90%
of cases [7]. The genetic mechanisms responsible for
CHD are complex, heterogeneous and incompletely
understood: approximately 8–12% is due to chromo-
somal anomalies, 3–25% to copy number variation and
3–5% to single gene defect [8]. These genetic variants,
de novo or inherited, concern genes involved in normal
cardiac development, altering signal transduction, tran-
scriptional regulation and encoding proteins. In some
cases the same genes have pleiotropic effects on other
organs [8] and this explains syndromic CHDs.
Clark EB [9] classified the CHDs according to the
pathogenesis: conotruncal defects are classified among
the anomalies of the migration of the ectomesenchyme,
in which there is an anomalous migration of component
of the secondary/anterior heart field. During heart devel-
opment the outflow tract develops by adding cells from
the pharyngeal mesoderm called the secondary/anterior
Fig. 3 Autopsy findings.: a sandal gap from first case; b microretrognathia, small mouth and low-set ears from second case
Table 1 Cardiopathy-associated genes evalueted
ACTA2 CFC1 FBN2 GDF2 MYH11 RASA1 TGFB2
ARHGAP31 CRELD1 FBN1 GATA4 MYLK RBM10 TGFB3
ACVR2B CITED2 FMN1 GDF1 MYH6 RBPJ TGFBR1
ACVRL1 COL3A1 FMN2 HAND2 MED12 SALL4 TGFBR2
ADAMTSL4 DOCK6 FOXC1 HAND1 MED12L SLC2A10 TGFBR3
BMPR1B/ALK6 DLL4 FOXH1 HEY2 NODAL SMAD3 TOPBP1
BCOR DIAPH2 FHOD1 ISL1 NFATC1 SOX7 TFAP2B
bcl9l DNAH11 FGF8 LEFTY1 NKX2–5 SKI TBX1
BMP4 DNAH5 FHOD3 LEFTY2 NAT10 SMAD4 TBX2
BMPR2 DIAPH1 FOXA2 JAM3 NKX2–6 SMAD1 TBX4
B3GAT3 EIF2AK4 FOXF1 JAG1 NOTCH1 SMAD6 TBX20
CRKL ELN FLNA KCNK3 NOTCH2 SMAD9 TBX3
CBLN2 EFEMP2 GDF1 MCTP2 NOTCH3 SALL1 ZIC3
CBS ENG GJA1 MID1 PITX2 TLL1 ZFPM2/FOG2
CAV1 ETS-1 GJA5 MAPK1 PPARG SHROOM3 ZDHHC9
CFAP53 EOGT GATA6 MHC6 PLOD1 TGFB1
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cardiac field [10], whereas the aorto-pulmonary septum
develops by condensation of cardiac neural crest (CNC)
cell – derived mesenchyme [11]. Alteration or loss of
these developmental processes leads to conotruncal
anomalies. The increasing studies of the genetic etiology
of CHDs allowed the identification of many genes in-
volved in specific morphogenetic mechanisms and re-
sponsible of specific cardiac phenotype, creating a link
between cause, pathogenetic mechanism and type of
malformation [12]. Conotruncal heart diseases are asso-
ciated with various chromosomal pathologies and mono-
genic syndromes: the most frequent associations of the
CAT are with DiGeorge syndrome, interstitial duplica-
tion of 8q and CHARGE syndrome, whereas the APW
can be associated to VACTERL association and
CHARGE syndrome [13]. Among the genetic variants
associated with conotruncal defects, the MED12 gene
does not currently appear. MED12 gene is located on
chromosome X and encodes a subunit of the Mediator
Complex, called mediator complex subunit 12, which is
crucial in RNA polymerase II transcription [14]. Zeb-
rafish models have shown that Med12, being co-
regulator of specific transcription factors, is necessary
during development: med12 zebrafish mutants showed
defects in neural crest formation, chondrogenesis and
organogenesis of the brain, liver, pancreas and kidney
[15, 16]. Zebrafish and mouse MED12-mutant dem-
onstrated the involvement of the MED12 gene in
heart development [17, 18].
Our study reports for the first time the finding of vari-
ant in the MED12 gene associated with syndromic CHD,
specifically associated with facial dysmorphisms. A prob-
able explanation of the role of the MED12 gene in deter-
mining conotruncal defect would be found in the
molecular mechanisms involved in embryonic develop-
ment of the heart: Med12 regulates gene-specific func-
tions during development and it is necessary for correct
Wnt/β-catenin signaling and Wnt/planar cell polarity
(PCP) pathway, as demonstrated on mouse models by
Rocha et al. [18] The consequent alteration of the Wnt
pathway and of the PCP signaling would therefore be re-
sponsible for the lack of migration of the CNC cells dur-
ing the formation of the aorto-pulmonary septum.
Schleiffarth et al [19] have indeed shown that the Wnt
signal, in particular Wnt5a, is necessary for the correct
development of the aorto-pulmonary septum and that
its loss is responsible for the development of conotrun-
cal defects.
The variant reported in our study is not described in
the international literature (PubMed/Medline) and in
the Catalog of Human Genes and Genetic Disorders
(OMIM) and it is currently to be considered VOUS
(Variants Of Uncertain Significance). The normal
phenotype of the mother carrying the variant on the X
chromosome in heterozygosity and the recurrence of the
pathological phenotype in fetuses both male with hemi-
zygous state increase the suspicion that this variant is
the cause of the pathology in these family patients and
that it may explain an X-linked transmission of syn-
dromic conotruncal defects, contributing to increase the
phenotypic range of MED12-related disorders. Therefore
it will have important implications for genetic and pre-
conception counseling, family planning and clinical
management.
In conclusion, despite we know many genetic varia-
tions involved in the development of CHDs and specific-
ally of CTDs, in most patients the genetic defects remain
unknown [1]. The latest investigation techniques such as
next generation sequencing (NGS) could increase our
knowledge about CHD genetic etiology. The variant
c.887G > A (p.Arg296Gln) in MED12 gene is a likely
pathogenic VOUS and it could shed new light on the
possible pathogenesis of conotruncal heart defects.
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